# Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

> **NCT03739775** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut Curie** · enrollment: 172 (estimated)

## Conditions studied

- HPV Positive Pelvic Cancer

## Interventions

- **PROCEDURE:** Blood sampling

## Key facts

- **NCT ID:** NCT03739775
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-24
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 172 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739775, "Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03739775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*